Carsyon 2 Te Egyan May 19

30 Questions | By Microlabs1 | Updated: Mar 20, 2022 | Attempts: 283

Questions

Settings

Feedback

During the Quiz End of Quiz

Play as

Quiz Flashcard

Create your own Quiz

. Welcome to TE E-GYAN Test Here is an opportunity to test your Product knowledge. You have 30 minutes to complete this test. Please enter your Name , Emp. Code ,HQ and Select your state. Then press "Start" to begin the test. You can only attend the test once and hence make sure you have uninterrupted internet connectivity. All the best Micro Leadership Academy

Questions and Answers

1.

The Punch line of Turbovas is
- A.
  
  Turbo power to Beat Dyslipidemia
- B.
  
  Turbo power to Bite Dyslipidemia
- C.
  
  Turbo power to Rid Dyslipidemia
- D.
  
  Turbo power to distroy Dyslipidemia
2.

ACC/AHA _________recommends High Intensity statin therapy in clinical ASCVD
- A.
  
  2018
- B.
  
  2019
- C.
  
  2017
- D.
  
  2010
3.

Turbovas CV contains
- A.
  
  Rosuvastatin 20 Mg + Clopidogrel 75 Tablets
- B.
  
  Rosuvastatin 10 Mg + Clopidogrel 75 Tablets
- C.
  
  Rosuvastatin 10 Mg + Clopidogrel 75 Capsules
- D.
  
  Rosuvastatin 20 Mg + Clopidogrel 75 Capsules
4.

Turbo power with added CV benefits is the punch line for which brand
- A.
  
  Turbovas CV
- B.
  
  Turbovas
- C.
  
  Turbovas Asp
- D.
  
  Turbovas F
5.

Rx _____________ In mixed dyslipidemia
- A.
  
  Turbovas
- B.
  
  Turbovas F
- C.
  
  Turbovas Cv
- D.
  
  Turbovas Asp
6.

USFDA has approved The only ARB with____________ cobination
- A.
  
  Hydrochlorothiazide
- B.
  
  Voglibose
- C.
  
  Chlorthalidone
- D.
  
  Glimepride
7.

Composition of Zilarta-CT is
- A.
  
  Azilsartan 40 mg + Chlorthalidone 1.25 mg Tablets
- B.
  
  Azilsartan 4 mg + Chlorthalidone 12.5 mg Capsules
- C.
  
  Azilsartan 40 mg + Chlorthalidone 12.5 mg Capsules
- D.
  
  Azilsartan 40 mg + Chlorthalidone 12.5 mg Tablets
8.

Zilarta-CT exhibits greater SBP & DBP than
- A.
  
  Telmesartan + Hydrochlorothiazide
- B.
  
  Olmesartan + Hydrochlorothiazide
- C.
  
  Amlodipine + Hydrochlorothiazide
- D.
  
  Clinidipine + Hydrochlorothiazide
9.

Azilsartan has completed ____ years of clinical journey
- A.
  
  2
- B.
  
  3
- C.
  
  1
- D.
  
  None of the above
10.

Azilsartan has >25 clinical studies involving __________ patients
- A.
  
  240000
- B.
  
  25000
- C.
  
  24000
- D.
  
  250000
11.

The recommended dosage of Zilarta in adults is _____mg OD.
- A.
  
  10
- B.
  
  20
- C.
  
  40
- D.
  
  80
12.

Voglinorm-GM forte 2 Reduces
- A.
  
  FBG
- B.
  
  PPBG
- C.
  
  HbA1C
- D.
  
  All of the above
13.

Voglibose reduces PPBG ______mg/dl after 6 months
- A.
  
  23.6
- B.
  
  44.1
- C.
  
  24.9
- D.
  
  32.6
14.

Puch line of Zilarta is
- A.
  
  24 hr Powerfull & Persistent BP control
- B.
  
  24 hr Potent t BP control
- C.
  
  24 hr Persistent BP control
- D.
  
  24 hr Potent & Persistent BP control
15.

Puch line of Zilarta-CT is
- A.
  
  Added Diuretic Power for Better CV Output
- B.
  
  Added Diuretic Powder for Better CV Outcomes
- C.
  
  Added Diuretic Power for Better CV events
- D.
  
  Added Diuretic Power for Better CV Outcomes
16.

Dr. Calls/Month
- A.
  
  Rs. 500 - Meet minimum 90% of expected 300 doctor calls in the month
- B.
  
  Rs. 600 - Meet minimum 80% of expected 300 doctor calls in the month
- C.
  
  Rs. 750 - eet minimum 70% of expected 300 doctor calls in the month
- D.
  
  Rs. 500 - Meet minimum 95% of expected 300 doctor calls in the month
17.

Core Dr Visit compliance
- A.
  
  Rs. 500 - Minimum 90% visit compliance of all core doctors (2/3 visits) as defined by division
- B.
  
  Rs. 650 - Minimum 95% visit compliance of all core doctors (2/3 visits) as defined by division
- C.
  
  Rs. 500 - Minimum 100% visit compliance of all core doctors (2/3 visits) as defined by division
- D.
  
  Rs. 750 - Minimum 100% visit compliance of all core doctors (2/3 visits) as defined by division
18.

Complete filling of RCPA, Detailing of brands, Samples and gift distribution , POBS
- A.
  
  Rs. 500 - Minimum for core and targeted doctors
- B.
  
  Rs. 600 - Minimum for core and targeted doctors& Chemist
- C.
  
  Rs. 750 - Minimum for core and targeted doctors,Chemsit & Stockist
- D.
  
  Rs. 500 - Minimum for core and targeted doctors,Chemist ,Stockist & c&f
19.

Early Sales Closing
- A.
  
  Rs. 500 - Achieve 70% of your sales by 21st of the month
- B.
  
  Rs. 750 - Achieve 70% of your sales by 22 ndof the month
- C.
  
  Rs. 600 - Achieve 70% of your sales by 31st of the month
- D.
  
  Rs. 100 - Achieve 70% of your sales by 20th of the month
20.

Disbursement will be quarterly (You should not have negative growth to earn call average, compliance, RCPA Norms incentive, with reporting schedule as per Company norms.)
- A.
  
  True
- B.
  
  False
21.

If PCPM is 1.5 Lac and growth is >=35% How much incentive TE will get
- A.
  
  3000
- B.
  
  3150
- C.
  
  2500
- D.
  
  3370
22.

If PCPM is 2.5 Lac and growth is >=30% how much incentive TE will earn
- A.
  
  8400
- B.
  
  8000
- C.
  
  8800
- D.
  
  8700
23.

Growth is calculated as
- A.
  
  LYS-CYS/LYS
- B.
  
  CYS-LYS/LYS
- C.
  
  LY/CY*100
- D.
  
  (CYS-LYS/LYS)*100
24.

TE PCPM is 3.80 lac and growth is >=25% what will his total earning of incentive
- A.
  
  12600
- B.
  
  13702
- C.
  
  12000
- D.
  
  13000
25.

If PCPM is 4.75 and growth is >30% what the incentive TE will get
- A.
  
  20900
- B.
  
  20650
- C.
  
  21600
- D.
  
  20000